Dorling Janet
Director at CymaBay Therapeutics, Inc.; Chief Commercial Officer at Achaogen Inc
- Sold, on record
- $568k
- Dollars the filings state
- Form 4 sales
- 7
- Latest Feb 12, 2024
- Form 144 notices
- 4
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- CymaBay Therapeutics, Inc.Director
- Achaogen IncChief Commercial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- CymaBay Therapeutics, Inc.25,000 shares
- Achaogen Inc2,331 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale CymaBay Therapeutics, Inc.RoutineNov 10, 2023 2023
Sold 7,000 shares at $15.24 ($107k)
Dorling Janet, Director
10b5-1 planSold 100% of holdings ($107k position)0 shares leftFirst sale on recordFiling
- 2 Form 144 notice CymaBay Therapeutics, Inc.NoticeNov 13, 2023 +3 days
Filed to sell 7,000 shares ($107k)
Dorling Janet, Director
10b5-1 planFiling
- 3 Form 4 sale CymaBay Therapeutics, Inc.RoutineDec 11, 2023 +28 days
Sold 6,000 shares at $20.07 ($120k)
Dorling Janet, Director
10b5-1 planSold 100% of holdings ($120k position)0 shares leftFollows a Form 144Filing
- 4 Form 144 notice CymaBay Therapeutics, Inc.NoticeDec 11, 2023 same day
Filed to sell 6,000 shares ($120k)
Dorling Janet, Director
10b5-1 planFiling
- 5 Form 4 sale CymaBay Therapeutics, Inc.RoutineJan 10, 2024 +30 days
Sold 6,000 shares at $23.86 ($143k)
Dorling Janet, Director
10b5-1 planSold 100% of holdings ($143k position)0 shares leftFollows a Form 144Filing
- 6 Form 144 notice CymaBay Therapeutics, Inc.NoticeJan 10, 2024 same day
Filed to sell 6,000 shares ($143k)
Dorling Janet, Director
10b5-1 planFiling
- 7 Form 144 notice CymaBay Therapeutics, Inc.NoticeFeb 12, 2024 +33 days
Filed to sell 6,000 shares ($192k)
Dorling Janet, Director
10b5-1 plan1x usual sizeFiling
- 8 Form 4 sale CymaBay Therapeutics, Inc.RoutineFeb 12, 2024 same day
Sold 6,000 shares at $31.97 ($192k)
Dorling Janet, Director
10b5-1 planSold 100% of holdings ($192k position)0 shares left1x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (11)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | Feb 14, 2024 | CymaBay Therapeutics, Inc. | Director | Form 4 sale | 6,000 | $192k | 100.0% | Routine | SEC |
| Feb 12, 2024 | Feb 12, 2024 | CymaBay Therapeutics, Inc. | Director | Form 144 notice | 6,000 | $192k | Notice | SEC | |
| Jan 10, 2024 | Jan 10, 2024 | CymaBay Therapeutics, Inc. | Director | Form 144 notice | 6,000 | $143k | Notice | SEC | |
| Jan 10, 2024 | Jan 10, 2024 | CymaBay Therapeutics, Inc. | Director | Form 4 sale | 6,000 | $143k | 100.0% | Routine | SEC |
| Dec 11, 2023 | Dec 11, 2023 | CymaBay Therapeutics, Inc. | Director | Form 144 notice | 6,000 | $120k | Notice | SEC | |
| Dec 11, 2023 | Dec 11, 2023 | CymaBay Therapeutics, Inc. | Director | Form 4 sale | 6,000 | $120k | 100.0% | Routine | SEC |
| Nov 13, 2023 | Nov 13, 2023 | CymaBay Therapeutics, Inc. | Director | Form 144 notice | 7,000 | $107k | Notice | SEC | |
| Nov 10, 2023 | Nov 14, 2023 | CymaBay Therapeutics, Inc. | Director | Form 4 sale | 7,000 | $107k | 100.0% | Routine | SEC |
| Feb 21, 2019 | Feb 25, 2019 | Achaogen Inc | Chief Commercial Officer | Form 4 sale | 1,063 | $946 | 0.4% | Plan not stated | SEC |
| Feb 5, 2019 | Feb 7, 2019 | Achaogen Inc | Chief Commercial Officer | Form 4 sale | 818 | $1k | 0.3% | Plan not stated | SEC |
| Jun 26, 2018 | Jun 28, 2018 | Achaogen Inc | Chief Commercial Officer | Form 4 sale | 450 | $4k | 1.9% | Plan not stated | SEC |